Transition Therapeutics Announces Fiscal 2010 Year End Financial Results
27 sept. 2010 16h01 HE
|
Transition Therapeutics Inc.
TORONTO, Sept. 27, 2010 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (Nasdaq:TTHI) (TSX:TTH) a product-focused biopharmaceutical company developing...
Transition Therapeutics to Hold Conference Call on Fiscal 2010 Year End Financial Results on Monday, September 27th, at 4:30 P.M. EDT
24 sept. 2010 17h01 HE
|
Transition Therapeutics Inc.
TORONTO, Sept. 24, 2010 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (Nasdaq:TTHI) (TSX:TTH) will hold a conference call on Monday, September 27, 2010 at 4:30 P.M....
Clinical Study of TT-223 in Combination With a GLP-1 Analogue Does Not Meet Study Efficacy Endpoints
17 sept. 2010 06h00 HE
|
Transition Therapeutics Inc.
TORONTO, Sept. 17, 2010 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (Nasdaq:TTHI) (TSX:TTH) announced today that a clinical study of gastrin analogue TT-223 in...
Transition Therapeutics Announces Initiation of a Phase I Clinical Study of TT-301
30 juin 2010 07h01 HE
|
Transition Therapeutics Inc.
TORONTO, June 30, 2010 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (Nasdaq:TTHI) (TSX:TTH) announced today that the first patient has been dosed with drug...
Transition Therapeutics to Present at Investor Conferences
07 juin 2010 11h25 HE
|
Transition Therapeutics Inc.
TORONTO, June 7, 2010 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (TSX:TTH) (Nasdaq:TTHI) announced today that Dr. Tony Cruz, Chairman and Chief Executive Officer...
Transition Therapeutics Announces Third Quarter Fiscal 2010 Financial Results
10 mai 2010 17h01 HE
|
Transition Therapeutics Inc.
TORONTO, May 10, 2010 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (Nasdaq:TTHI) (TSX:TTH), a product-focused biopharmaceutical company developing therapeutics...
Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2010 Financial Results on Tuesday, May 11th, at 8:30 A.M. EDT
10 mai 2010 08h31 HE
|
Transition Therapeutics Inc.
TORONTO, May 10, 2010 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (Nasdaq:TTHI) (TSX:TTH) will hold a conference call on Tuesday, May 11, 2010 at 8:30 A.M. EDT to...
Transition Therapeutics Announces Licensing and Collaboration Agreement With Lilly
03 mars 2010 06h01 HE
|
Transition Therapeutics Inc.
TORONTO, March 3, 2010 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. (TSX:TTH) (Nasdaq:TTHI) today announced that it has acquired the rights to a series of preclinical compounds from Eli Lilly and...
Transition Therapeutics to Present at Upcoming Conferences
25 févr. 2010 06h01 HE
|
Transition Therapeutics Inc.
TORONTO, Feb. 25, 2010 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (TSX:TTH) (Nasdaq:TTHI) announced today that Dr. Tony Cruz, Chairman and Chief Executive Officer...
Transition Therapeutics Announces Second Quarter Fiscal 2010 Financial Results
10 févr. 2010 16h01 HE
|
Transition Therapeutics Inc.
TORONTO, Feb. 10, 2010 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (TSX:TTH) (Nasdaq:TTHI), a product-focused biopharmaceutical company developing therapeutics for...